Biotech / Medical
Neptune Technologies & Bioressources Inc. - NTB.V
An SI Board Since July 2011
Posts SubjectMarks Bans Symbol
524 14 0 NEPT
Emcee:  Sultan Type:  Unmoderated
Neptune Wellness Solutions researches, develops and commercializes proprietary bioactive
ingredients and products with the goal of superior added-value and clinically proven health benefits. The
Company extracts a range of bioactive ingredients such as novel proprietary omega-3 phospholipids from
abundant yet underexploited marine biomass including Krill, a cold deep water zooplankton. Neptune’s
first commercially available product is Neptune Krill Oil (NKO®), which represents marine based omega-3
phospholipids with potential in cardiovascular, cognitive and anti-inflammatory disorders. Neptune is pursuing
market opportunities in the nutraceutical market including dietary supplements and functional foods. The
Company is also pursuing opportunities in the pharmaceutical market through its pharmaceutical subsidiaries,Acasti and NeuroBioPharm (including medical food, over-the-counter and prescription drug applications).

NOTE: Neptune trades on Toronto.. For Canadian & US quote, enter NEPT

Acasti Pharma Inc. is 35% owned by Neptune.. For Canadian & US quote, enter ACST
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
524Neptune Announces First Quarter Results Phase I Investment of the Cannabis BusSultan-an hour ago
523Acasti Pharma Provides Business Update for the First Quarter of Fiscal 2019 finSultan-yesterday
522Neptune Files Two Patent Applications for Innovative Cannabis Extraction ProcessSultan-last Thursday
521Perceptive Advisors, LLC inceases its position in Neptune Technologies & BioSultan-last Wednesday
520Insider Buy John Morris Moretz, Chairman of the BOD added 64,755 shares at USD Sultan-August 7
519Acasti Pharma Awarded Composition-of-Matter Patent by the U.S. Patent and TrademSultan-July 25
518Institutional Ownership apps.cnbc.comSultan-July 10
517Neptune has filed a 40 page Processing Agreement with Canopy on toSultan-July 4
516TD Bank adds 16 more cannabis stocks to approved list Clare O’Hara and ChristinSultan-July 2
515Annual Information Form has been filed on sedar.comSultan-June 29
514Acasti Pharma Business Update for the Fourth Quarter and Fiscal 2018 Patient eSultan-June 27
513 Canopy Growth Corp CEO Linton says big pharma should be very afraid of WEED caSultan-June 22
512From TD Direct Investing (some one posted this on Neptune TechnSultan1June 20
511Neptune Tech up 33% premarket on Canopy Growth deal Thinly traded micro cap NepE_K_S-June 20
510June Presentation neptunecorp.comSultan-June 20
509Translation of the previous link Marijuana: Neptune gets along with Canopy, thSultan-June 20
508 Marijuana: Neptune s'entend avec Canopy, l'action explose Sultan-June 20
507Marijuana legalization Bill C-45 officially passes Senate vote, heading for royaSultan1June 19
506Echelon ups Neptune Wellness PT to $8 Echelon Wealth Partners hiked its price tSultan-June 19
505Neptune Tech up 33% premarket on Canopy Growth deal Thinly traded micro cap NepE_K_S-June 19
504Acasti Pharma Reports on Positive Feedback Following Today’s Presentation at theSultan-June 14
503 Neptune Technologies & Bioresources Inc.'s (NEPT) CEO Jim Hamilton on QSultan-June 8
502Neptune Wellness Solutions is a buy, Echelon Wealth says cantechletter.comSultan-June 7
501Neptune Announces Fourth Quarter and Year-end Results CC PrSultan-June 5
500 A Roadmap to Understanding Hemp & Marijuana Ingredients in Canada and the USultan-June 5
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2018 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.